Impact of age and gender on adherence to infection control guidelines and medical regimens in cystic fibrosis

Pediatric Pulmonology

Volumn 46, Issue 3, 2011, Pages 295-301

  Masterson, Tracy Loye ^a   Wildman, Beth G ^b   Newberry, Benjamin H ^b   Omlor, Gregory J ^c  

^a JOHN CARROLL UNIVERSITY   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c AKRON CHILDREN'S HOSPITAL   (United States)

Author keywords

Adherence; Age; Cystic fibrosis; Gender; Infection control

Indexed keywords

ANTIBIOTIC AGENT; ENZYME; STEROID; VITAMIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIET SUPPLEMENTATION; FEMALE; HEALTH BELIEF; HUMAN; INFECTION CONTROL; LUNG CLEARANCE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE; AGE; CYSTIC FIBROSIS; MIDDLE AGED; PRACTICE GUIDELINE; STANDARDS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CYSTIC FIBROSIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 79951784653     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21366     Document Type: Article

References (45)

1. Cystic Fibrosis Foundation: Patient Registry 2007. Bethesda, MD: Cystic Fibrosis Foundation Annual Report, 2008.
2. Bluebond-Langner M, Lask B, Angst DB, editors. Psychosocial aspects of cystic fibrosis. New York: Oxford University Press; 2001.
3. Saiman L, Siegel J. The Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol (Suppl) 2003;24:6-52.
4. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertso CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704. (Pubitemid 32417671)
5. Cystic Fibrosis Foundation: Patient Registry 2007. Besthesda, MD: Cystic Fibrosis Foundation Annual Report, 2008.
6. Govan JR, Brown OH, Maddison J, Doherty JW, Nelson M, Dodd AP, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-19. (Pubitemid 23183915)
7. Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177-181. (Pubitemid 30141793)
8. Zuckerman JB, Zuaro DE, Prato BS, Ruoff KL, Sawicki RW, Quinton HB, Saiman L. Bacterial contamination in cystic fibrosis clinic. J Cyst Fibros 2009;8:186-192.
9. Festini F, Buzzetti R, Bassi C, Braggion C, Salvatore D, Taccetti G, Mastella G. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: A systematic review. J Hosp Infect 2006;64:1-6. (Pubitemid 44161372)
10. Cystic Fibrosis Foundation: Patient Registry 2004. Besthesda, MD: Cystic Fibrosis Foundation Annual Report, 2005.
11. Griffiths AL, Armstrong D, Carzino R, Robinson P. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J 2004;24:449-452. (Pubitemid 39232269)
12. Masterson TL, Wildman BG, Newberry B, Omlor GM, Bryson E, Kukay A. Compliance in cystic fibrosis: an examination of infection control guidelines. Pediatr Pulmonol 2008;43:435-442. (Pubitemid 351657309)
13. Ullrich G, Wiedau S, Schultz W, Steinkamp G. Parental knowledge and behaviour to prevent environmental P. aeruginosa acquisition in their children with CF. J Cyst Fibros 2008;7:231-237. (Pubitemid 351650271)
14. Garber E, Desai M, Zhou J, Alba L, Angst D, Cabana M, Saiman L. Barriers to adherence to cystic fibrosis infection control guidelines. Pediatr Pulmonol 2008;43:900-907.
15. Rapoff M, Christophersen E. Compliance of pediatric patients with medical regimens: a review and evaluation. In: Stuart R, editor. Adherence, compliance and generalization in behavioral medicine. New York: Brunner/Mazel; 1982. pp. 79-124.
16. White D, Stiller K, Haensel N. Adherence of adult cystic fibrosis patients with airway clearance and exercise regimens. J Cyst Fibros 2007;6:163-170. (Pubitemid 46567782)
17. Myers LB, Horn SA. Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006;11:915-926. (Pubitemid 44545814)
18. Drotar D, Ievers C. Age differences in parent and child responsibilities for management of cystic fibrosis and insulin-dependent diabetes mellitus. Dev Behav Pediatr 1994;15:265-272.
19. Wysocki T, Taylor A, Hough B, Linscheid TR, Yeates KO, Naglieri JA. Deviation from developmentally appropriate selfcare autonomy: associations with diabetes outcomes. Diabetes Care 1996;19:119-125.
20. Geiss SK, Hobbs SA, Hammerley-Maercklein G, Kramer JC, Henley M. Psychosocial factors related to perceived compliance in cystic fibrosis treatments. J Clin Psychol 1992;48:99-103.
21. Ricker JH, Delamater AM, Hsu J. Correlates of regimen adherence in cystic fibrosis. J Clin Psychol Med Sch 1998;5:159-172.
22. Tebbi CK, Cummings M, Zevon MA, Smith L, Richards M, Mallon J. Compliance of pediatric and adolescent cancer patients. Cancer 1986;58:1179-1184. (Pubitemid 16046957)
23. Gudas LJ, Koocher GP, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis. Dev Behav Pediatr 1991;12:236-242.
24. Hamutcu R, Rowland JM, Horn MV, Kaminsky C, McLaughlin EF, Starnes VA, Woo MS. Clinical findings and lung pathology in children with cystic fibrosis. Am J Resp Crit Care 2002;165:1172-1175. (Pubitemid 34415829)
25. Hegarty M, Macdonald J, Watter P, Wilson C. Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions. Child Care Health Dev 2009;35:462-468.
26. Reis HT, Collins WA, Berscheid E. The relationship context of human behavior and development. Psychol Bull 2000;126:844-872.
27. Czajkowski DR, Koocher GP. Medical compliance and coping with cystic fibrosis. J Child Psychol Psychiatry 1987;28:311-319.
28. Patterson JM, Wall M, Berge J, et al. Gender differences in treatment adherence among youth with cystic fibrosis: development of a new questionnaire. J Cyst Fibros 2008;7:154-164. (Pubitemid 351372765)
29. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997;145:794-803. (Pubitemid 27188516)
30. Willis E, Miller R, Wyn J. Gender embodiment and survival for young people with cystic fibrosis. Soc Sci Med 2001;53:1163-1174. (Pubitemid 32758759)
31. Berndt TJ. The features and effects of friendship in early adolescence. Child Dev 1982;53:1447-1460.
32. La Greca AM, Swales T, Klemp S, Madigan S, Skyler J. Self-care behaviors among adolescents with diabetes. 9th Annual Sessions of the Society of Behavioral Medicine, Baltimore, MD; 1988.
33. Champion VL. Instrument development for health belief model constructs. Adv Nurs Sci 1984;6:73-85.
34. Grol R. National standard setting for quality of care in general practice: attitudes of general practitioners and response to a set of standards. Br J Gen Pract 1990;40:361-364.
35. DiGirolamo AM, Quittner AL, Ackerman V, Stevens J. Identification and assessment of ongoing stressors in adolescents with a chronic illness: an application of the Behavior Analytic Model. J Clin Psychol 1997;26:53-66.
36. Kyngäs HA, Kroll T, Duffy ME. Compliance in adolescence with chronic diseases: a review. J Adolesc Health 2000;26:379-388. (Pubitemid 30259099)
37. Elkind D. Egocentrism in adolescence. Child Dev 1967;38:1025-1034.
38. Naar-King S, Idalski A, Ellis D, Frey M, Templin T, Cunningham PB, Cakan N. Gender differences in adherence and metabolic control in urban youth with poorly controlled type 1 diabetes: the mediating role of mental health symptoms. J Pediatr Psychol 2006;31:793-802. (Pubitemid 44310206)
39. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Int Med 2004;19:1111-1117. (Pubitemid 39552581)
40. Strecher VJ, Rosenstock LM. The health belief model. In: Glanz K, Lewis F, Rimer BK, editors. Health behavior and health education: theory, research & practice, 2nd edition. San Francisco, CA: Jossey-Bass; 1996. pp. 41-59.
41. Rosenstock IM. The health belief model and preventative health behavior. Health Educ Monogr 1974;2:354-386.
42. Quittner AL, Drotar D, Ievers-Landis C. Adherence to medical treatments in individuals with cystic fibrosis: the development and evaluation of family-based interventions. In: Drotar D, editor. Promoting adherence to medical treatments in chronic illness: concepts, methods, and interventions. Mahwah, NJ: Lawrence Erlbaum Associates; 2000. pp. 393-407.
43. Flume PA, Anderson DL, Hardy KK, Gray S. Transition programs in cystic fibrosis centers: perceptions of pediatric and adult program directors. Pediatr Pulmonol 2001;31:443-450. (Pubitemid 32523637)
44. Burroughs TE, Pontious SL, Santiago JV. The relationship among six psychosocial domains, age, health care adherence, and metabolic control in adolescents with IDDM. Diab Educ 1993;19:396-402.
45. Marciel KK, Saiman L, Quittell LM, Dawkins K, Quittner AL. Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatr Pulmonol 2009;45:157-164.